title: Cystatin C--a marker of peripheral atherosclerotic disease?
abstract: It has been suggested that Cystatin C, besides its function as a marker of glomerular filtration, could be an independent marker of cardiovascular disease. However, studies on this topic are few and results have been indecisive. Our aim was to further investigate the subject of Cystatin C as an independent marker of peripheral atherosclerotic disease.
  
  
  METHODS
  Blood samples were analysed for serum Cystatin C, IL6, CRP and creatinine in 103 males with peripheral arterial disease (PAD) and 96 controls matched for age and sex. Creatinine clearance (CCr) was calculated according to Cockcroft's formula and estimated glomerular filtration rate (eGFR) was calculated according to MDRD formula.
  
  
  RESULTS
  Cystatin C-concentration was higher in PAD-patients compared to controls; 1.09+/-0.40 vs. 0.95+/-0.17 mg/L (p<0.01). There was no difference in CCr; 81+/-27 vs. 82+/-22 mL/min or eGFR; 76+/-21 vs. 79+/-14 mL/min. Cystatin C correlated to CCr, logIL-6 and logCRP in both patients (r=-0.60, p<0.001), (r=0.35, p<0.001) and (r=0.30, p<0.01) and controls (-0.44, p<0.001), (0.38, p<0.001) and (r=0.32, p<0.01), respectively. In an analysis of covariance, corrected for difference in eGFR, Cystatin C remained higher in PAD-patients compared to controls; 1.09 (C.I. 1.04-1.14) vs. 0.96 (C.I. 0.90-1.01).
  
  
  CONCLUSIONS
  Cystatin C-concentration, corrected for differences in eGFR, IL-6 and CRP values, is higher in PAD-patients compared to controls. Our finding suggests that Cystatin C may be an independent marker of atherosclerotic disease apart from its relation to kidney function.
authors.affiliation: Department of Medicine, Division of Emergency Medicine, Karolinska University Hospital-Solna, Stockholm, Sweden.
authors.forename: J
authors.initials: J
authors.lastname: Arpegård
authors.forename: J
authors.initials: J
authors.lastname: Ostergren
authors.forename: U
authors.initials: U
authors.lastname: de Faire
authors.forename: L-O
authors.initials: LO
authors.lastname: Hansson
authors.forename: P
authors.initials: P
authors.lastname: Svensson
mesh_terms: D000368:Aged; D050197:Atherosclerosis / Q000097:blood* / Q000473:pathology; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure; D016022:Case-Control Studies; D055316:Cystatin C; D015891:Cystatins / Q000097:blood* / Q000378:metabolism; D005919:Glomerular Filtration Rate; D006801:Humans; D007249:Inflammation; D015850:Interleukin-6 / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D008954:Models, Biological
chemical_list: D015415:Biomarkers; C525030:CST3 protein, human; D055316:Cystatin C; D015891:Cystatins; D015850:Interleukin-6